Xtant Medical Holdings, Inc. (XTNT)
| Market Cap | 113.75M |
| Revenue (ttm) | 56.29M |
| Net Income (ttm) | -7.92M |
| Shares Out | 13.23M |
| EPS (ttm) | -0.61 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 25 |
| Last Price | $1.58 |
| Previous Close | $1.48 |
| Change ($) | 0.10 |
| Change (%) | 6.76% |
| Day's Open | 1.51 |
| Day's Range | 1.48 - 1.60 |
| Day's Volume | 222,471 |
| 52-Week Range | 0.62 - 1.74 |
BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q3 2020 Results - Earnings Call Transcript
BELGRADE, Mont., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
BELGRADE, Mont., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
BELGRADE, Mont., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
BELGRADE, Mont., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
Xtant Medical Holdings news on Friday has XTNT stock skyrocketing after the company announced the completion of their debt restructuring plan. The post XTNT Stock Skyrockets After Xtant Medica...
BELGRADE, Mont., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...
BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...
PHILADELPHIA, Aug. 15, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q2 2020 Results - Earnings Call Transcript
BELGRADE, Mont., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...
BELGRADE, Mont., July 30, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q1 2020 Results - Earnings Call Transcript
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q4 2019 Results - Earnings Call Transcript
Xtant Medical Holdings' (XTNT) CEO Sean Browne on Q3 2019 Results - Earnings Call Transcript
BELGRADE, Mont., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...
BELGRADE, Mont., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of...
Xtant Medical Holdings, Inc. (XTNT) Management on Q2 2019 Results - Earnings Call Transcript
Xtant Medical Holdings, Inc. (XTNT) Q1 2019 Results - Earnings Call Transcript
Xtant Medical Holdings' (XTNT) Management on Q4 2018 Results - Earnings Call Transcript
About XTNT
Xtant Medical Holdings develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bon... [Read more...]
| Industry Medical Devices | |
| CEO Sean Browne | Employees 141 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol XTNT |
Financial Performance
In 2019, XTNT's revenue was $64.68 million, a decrease of -10.42% compared to the previous year's $72.20 million. Losses were -$8.22 million, -88.27% less than in 2018.
Analyst Forecasts
According to one analyst, the rating for XTNT stock is "Hold" and the 12-month stock price forecast is 1.00.